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Abstract
Background: Recent studies have shown the public health importance of identifying acute HIV infection (AHI) in the men
who have sex with men (MSM) of China, which has a much higher risk of HIV transmission. However, cost-utility analyses to
guide policy around AHI screening are lacking.
Methodology/Principal Findings: An open prospective cohort was recruited among MSM living in Liaoning Province,
Northeast China. Blood samples and epidemiological information were collected every 10 weeks. Third-generation ELISA
and rapid test were used for HIV antibody screening, western blot assay (WB) served for assay validation. Antibody negative
specimens were tested with 24 mini-pool nucleic acid amplification testing (NAAT). Specimens with positive ELISA but
negative or indeterminate WB results were tested with NAAT individually without mixing. A cost-utility analysis of NAAT
screening was assessed. Among the 5,344 follow-up visits of 1,765 MSM in 22 months, HIV antibody tests detected 114 HIV
chronic infections, 24 seroconverters and 21 antibody indeterminate cases. 29 acute HIV infections were detected with
NAAT from 21 antibody indeterminate and 1,606 antibody negative cases. The HIV-1 prevalence and incidence density were
6.6% (95% CI: 5.5–7.9) and 7.1 (95% CI: 5.4–9.2)/100 person-years, respectively. With pooled NAAT and individual NAAT
strategy, the cost of an HIV transmission averted was $1,480. The addition of NAAT after HIV antibody tests had a cost-utility
ratio of $3,366 per gained quality-adjusted life year (QALY). The input-output ratio of NAAT was about 1:16.9.
Conclusions/Significance: The HIV infections among MSM continue to rise at alarming rates. Despite the rising cost, adding
pooled NAAT to the HIV antibody screening significantly increases the identification of acute HIV infections in MSM. Early
treatment and target-oriented publicity and education programs can be strengthened to decrease the risk of HIV
transmission and to save medical resources in the long run.
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Introduction
Recent data indicate that human immunodeficiency virus (HIV)
infections have been rising sharply among the men who have sex
with men (MSM) high-risk population in China [1,2,3,4,5]. In a
recent large-scale national survey conducted in 2008 across 61
cities throughout China, covering over 18,000 MSM, the
prevalence of human immunodeficiency virus (HIV) was 4.9%
and incidence ranged from 2.6 to 5.4 per 100 person-years [6].
MSM is becoming one of the most important target populations
for HIV prevention in China. The increasing trends of HIV
infection in the MSM population also reported in the neighboring
countries, such as Thailand [7], Myanmar [8] India [9] and
Russia [10]. Liaoning Province is an important industrial province
located in Northeast China with an estimated population of
approximately 43 million people, among which 400,000 are MSM
[11]. The MSM population in Liaoning is sexually active, often
with multiple sex partners and occasional sex partners [1,12]. The
HIV prevalence in Liaoning MSM is increasing rapidly, as
demonstrated by a recent prospective cohort study reporting the
HIV incidence density of Shenyang, the capital of Liaoning, to
reach 5.4/100 person-years [1]. Early detection of acutely infected
HIV cases will allow behavioral interventions to become more
readily available to patients, thereby preventing second-generation
transmission through high-risk behavior reduction. Furthermore,
the HIV infected individual can receive earlier treatment and
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[13,14].
Third-generation enzyme-linked immunosorbent assay (ELISA)
plus western blot were routinely used in HIV infection screening in
both develpoed and developing countries in the world [15,16,17].
Since routine HIV antibody tests yield negative results during the
first several weeks prior to seroconversion, acute infections can be
diagnosed during this window period only with the use of tests for
viral antigens and nucleic acids [18,19]. In many developed
countries, pooled NAAT were routinely used to detect the acute
HIV infection (AHI) in antibody negative blood donation samples
to reduce the residual risk of HIV transmission during the
seronegative window period [20,21,22,23]. Reports from devel-
oped countries showed limited marginal value to NAAT blood
screening in improving blood safety [20,21,24], because the HIV
prevalence was rather low and the number of donors in the
window period at the time of donation was generally very low in
those countries. With regards to the cost-effectiveness of pooled
NAAT to detect AHI in the general population and high-risk sub-
populations, some studies reported that pooled NAAT screening
for AHI was not likely to be cost-effective in most settings, except
for high-risk persons with very high incidences [25,26,27].
Although pooled NAAT can identify a substantial increased
proportion of AHI at high risk for further HIV transmission [28],
there has been no systematical research on the cost-effectiveness of
AHI screening through HIV-1 antibody test and pooled NAAT in
a high-risk population with high HIV incidence, especially in a
cohort study.
In this study, we recruited a large-scale open prospective cohort
of high-risk MSM from Voluntary Counseling and Testing (VCT)
centers in three cities of Liaoning Province: Shenyang, Anshan
and Fushun. This is the first large-scale prospective cohort in
China utilizing third-generation ELISA antibody test and pooled
NAAT for HIV screening. We aim to elucidate the HIV
prevalence and incidence in this MSM high-risk population as
well as analyze the cost-utility of pooled NAAT HIV testing on
identifying acute HIV infections. This study is helpful for further
investigating the newest trends of HIV infection in the MSM high-
risk population and for deciding upon scientific control and
medical resource configuration strategies.
Results
Cohort Follow-up
Between February 2009 and September 2010, 1765 MSM from
Liaoning Province who met the inclusion criteria were recruited.
In total, there were 5400 person times follow-up in the observation
period, among which, 5344 person times follow-up were effective.
56 person times follow-up were excluded due to insufficient data.
Among the 1765 cases, 1056 (59.8%) were followed-up for two or
more times.
HIV-1 Infection Identification
Among the 5344 blood samples, 5182 were negative and 162
were positive in the third-generation ELISA and the rapid HIV
antibody test. After confirming with WB, 138 met the HIV-
positive standard, including 114 baseline samples and 24 follow-
up seroconversion samples. The latter were diagnosed as recent
HIV infections. There were 21 samples with ELISA positive but
WB indeterminate results, including 3 baseline samples and 18
follow-up samples. The 21 cases were all positive in NAAT and
were diagnosed acute HIV infections due to an increase of bands
in their follow-up samples confirmed with WB. Another 3
samples with positive ELISA but negative WB results were all
negative in NAAT. No changes in HIV specific bands were
detected in follow-up samples; therefore, these 3 cases were
considered to be false positives for HIV antibody screening. To
find serological window period HIV infected cases, 5182 antibody
negative samples were mixed according to the 24 mini-pool
strategy. Among them, 14 NAAT positive samples were detected.
After follow-up, 8 cases that became seropositive were considered
to be window period acute HIV infections, while another 4 cases
that remained seronegative were considered to be false positives
of the pooled NAAT. The remaining two cases were lost to
follow-up, whose HIV statuses could not be confirmed thus were
excluded from the following calculation. According to the
aforementioned results and the epidemiology surveys, 114
chronic HIV infections and 53 acute or recent HIV infections
were found. The latter included 24 seroconversion cases, 21
antibody positive/WB indeterminate/NAAT positive cases, as
well as 8 serological window period cases. Overall, the calculated
HIV prevalence and incidence in the MSM population in
Liaoning were 6.6 (95% CI: 5.5–7.9) and 7.1 (95% CI: 5.4–9.2)/
100 person-years, respectively (see Figure 1).
Validity and predictive effect of the third-generation
ELISA and NAAT
In this study, the golden standard consisted of a positive ELISA
confirmed with western blot assay in the observation period. The
sensitivity and specificity of the third-generation ELISA HIV
antibody test for this MSM high risk population were
95.21%(95%CI: 90.78–97.91%) and 99.95%(95%CI: 99.83–
99.99%), respectively. The positive predictive value of the third-
generation ELISA HIV antibody test on this MSM high risk
population was 98.15% (95%CI: (94.68–99.62%)). The sensitivity
and specificity of pooled NAAT were 100% and 99.92%(95%:
99.80–99.98%), respectively. The positive predictive value of the
pooled and individual NAAT after serological assay was 87.88%
(95%CI, 71.80–96.60%) (Table 1). As a result, combining pooled
or individual NAAT with third-generation ELISA, the sensitivity
increased by 4.79% at the cost of 0.03% drop in specificity.
Cost-effectiveness of Early Identification of Acute
Infection with NAAT
With the HIV antibody assay, the cost was $3 for each
specimen,$114 for each HIV infection, and $656 for each recent
HIV infection identified. The addition of pooled NAAT after a
third-generation ELISA to detect AHI, resulted in additional cost
of $5.6 per specimen, $998 per acute HIV infection, and $3618
per window period acute HIV infection identified averagely.
However, the addition of NAAT was estimated to avert 19.56
HIV transmissions, according to the formula in the methods. The
cost of each HIV transmission averted was $1480. Based on the
first-line antiretroviral regimen and monitoring programme
currently used in China, the expense on treatment, CD4 count,
and viral load monitoring was estimated to be $781. The
additional life expectancy for HIV-1 patients treated with
HAART was 32 years. The total cost of treatment and monitoring
for each transmitted HIV infection within the life expectancy was
$25000. The total averted treatment and monitoring expense was
$489012. This means $460070 would be saved at the cost of
$28942 on NAAT. The input-output ratio was 1:16.9. Based upon
the average life span for Chinese males, 7 QALYs were lost due to
HIV infection for each patient in the HAART era and 136.9
QALYs lost can be averted in total. Therefore, the addition of
pooled NAAT after third-generation ELISA to detect AHI had a
cost-utility ratio of $3360 per gained QALY.
Screening Acute HIV Infections in MSM
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ELISA is the screening test that is commonly used for detection
of HIV antibodies. Since it was first introduced in 1985, numerous
commercial ELISA assays have been developed. Most of the first
generation ELISA tests used viral lysate antigens that frequently
had nonspecific reactions between the antibodies and the cell
antigens. The second generation ELISA assays used recombinant
proteins and/or synthetic peptides. However, these assays
usually employed a conserved region of the HIV proteins and
many of them failed to detect highly divergent HIV subtypes.
The earlier generations of ELISAs usually had a 6 to 12 weeks
window period. Targeting both IgM and IgG, the third-
generation ELISA assays shorten the window period to about
Figure 1. Flow Chart of the Study MSM High-risk Population and HIV Infection Detection Process. The numbers of study samples, HIV
detection assays and the number of different results are shown in the flow chart. The different HIV statuses are indicated in the shaded areas. HIV
prevalence and incidence are calculated based on the numbers in the shaded areas.
doi:10.1371/journal.pone.0028792.g001
Table 1. Performance of 3
rd ELISA and NAAT on HIV Diagnosis in MSM High-risk Population.
Diagnostic Test Results
HIV Infected
Subjects (n)
Uninfected
Subjects (n)
Total
(n)
Sensitivity %
(95%CI)
Specificity %
(95%CI)
positive predictive
value % (95%CI)
3
rd ELISA Positive 159 3 162 95.21% (90.78–97.91%) 99.95% (99.83–99.99%) 98.15% (94.68–99.62%)
Negative 8 5174 5182
Total 167 5177 5344
Pooled/Individual NAAT Positive 29 4 33 100% 99.92% (99.80–99.98%) 87.88% (71.80–96.60%)
Negative 0 5171 5171
Total 29 5175 5204
doi:10.1371/journal.pone.0028792.t001
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shortened to about 2 weeks with 4th generation ELISA that
simultaneously detect both antigen and antibody [26]. Until
recently, third-generation ELISA HIV antibody assay was still
the fundamental tool for HIV detection in most hospitals and
disease prevention and control centers in China. However, in
this study, we found that the third generation ELISA HIV
antibody assay can only correctly detect 95.21% of HIV
infections in the MSM high-risk population, which is signifi-
cantly lower than its performance for low risk populations. The
main reason for the relatively low sensitivity is because the HIV
incidence of MSM population was as high as 7.1/100 person-
years. Some acute HIV infectioned cases were still seronegative
or the antibody titer had not reach the lowest detection limit of
the third-generation ELISA. So, third-generation ELISA is not
enough for acute HIV infection screening in populations with
high HIV incidence.
In the early stage of HIV-1 infection, the viremia arises before
the production of antigen and antibody. Therefore, theoretically,
NAAT can detect the evidence of HIV infection earlier. In this
study, all antibody negative samples were mixed into 24 mini-pools
for HIV NAAT, the low detection limit for the first level pools was
as low as 40 copies/ml, the low detection limit for each sample was
960 copies/ml theoretically,, far below the general level of acute
HIV infection [31]. 8 serological window period acute HIV
infections were detected and confirmed. The sensitivities of third-
generation ELISA and pooled NAAT were 95.21% and 100%,
respectively. Therefore, in the MSM high risk population, the
sensitivity increased greatly by combining NAAT with third-
generation ELISA. It is important to note that the positive
predictive value of the pooled and individual NAAT after
serological assay was only 87.88%. Because of the high sensitivity
of NAAT, the false positives are common. The contamination is
mainly caused by carry-over from previous PCR products and the
cross-contamination among samples and reagents. Therefore, in
clinical NAAT, the blank control, the negative sample control and
reagents control should be included. In pooled NAAT, the
negative pooled control and positive pooled controls should be
added in order to control the error associated with a manual
sample mixing process. However the false positive cannot be
avoided completely. Thus, the possibility of false positives is a
disadvantage of NAAT.
In in the observation period of this open prospective cohort
study, 114 established HIV infections and 53 acute/recent HIV
infections were detected. If only ELISA and WB were used, 29
antibody negative or indeterminate acute HIV infections would
fail to be diagnosed in a timely fashion. If NAAT was also applied
for diagnosis, the cost of detecting an acute HIV infection was
$998, which is close to 1.5 times of the cost of an acute infection
diagnosis with antibody targeting assay only. Furthermore, the
cost of detecting a window period HIV infection reached $3618.
Although much less than the cost in public health settings of the
United States [25], the cost of pooled NAAT was high even in
high-risk populations with high HIV incidences. In this study,
there were several major factors affecting cost. First, to control
the potential contamination, the negative control, low positive
control, high positive control, negative pooled control and
positive pooled control were included in each of the 24 assays,
which increased the total cost by 38.9%. Second, because of the
high mobility and limited compliance of this MSM high risk
population, follow-up rate of this cohort reached just 59.8%.
Some potential HIV seroconverted cases could not be reached for
follow-up, which may have impacted the acute HIV infection
detection rate. Therefore, if the follow-up rate could be increased,
the costs of acute and window period HIV infections diagnosis
would be lower. Third, in this study, the widely used third
generation ELISA HIV antibody assay was adopted instead of
the commercialized fourth generation HIV ELISA assays, even
though the fourth HIV ELISA shortens the window period of
serologic assays [18,32]. In our study, 6 of the 8 window period
positive samples were detected with fourth generation ELISA,
and 4 of which were proved to be positive, although they were
not presented in our results. Therefore, if the fourth generation
ELISA assay was used in this whole study, more acute HIV
infections would be detected with serologic assays,which would
greatly reduce the likelihood of utilizing the pool splitting process,
thus reducing the cost of NAAT. Furthermore, for the cost of
commercial fourth generation ELISA is similar to third
generation ELISA in China, and so using fourth generation
ELISA in serologic screening would not produce more cost itself,
but the frequency and cost on the confirmation of the HIV
antigen would need to be evaluated. The cost of pooled NAAT
varied greatly among other studies abroad depending on the
target population and detection strategy, but the cost determined
in this study was generally lower than that of other studies
[15,28].
It is reported that the viral load in acute infection stage is at its
peak level of the disease process [31], and the transmission
efficiency is much higher than in chronic HIV infections and
Acquired Immune Deficiency Syndrome (AIDS) patients
[33,34,35]. Therefore, an acute HIV infection has a higher
dissemination risk from a public health perspective. Pooled
NAAT can improve the detection rate of acute HIV infections
significantly. By informing patients of their HIV status,
promoting knowledge of AIDS prevention, teaching patients
how to take effective protective measures, and treating them with
the appropriate drugs, we can reduce the transmission ability of
the acutely infected HIV patients considerably. Since 2002, HIV
infected patients can receive HAART treatment freely under the
‘‘four free and one care’’ policy in China. Based on the current
first-line antiretroviral regimen, the Chinese government will
spend about $781 on treatment, CD4 count, and viral load
monitoring for each HIV infected case per year. Obviously, this is
a heavy economic burden. In this study, through the actual
expenses of the HIV screening assay and the calculated second
generation HIV transmissions averted using previously published
parameters of the MSM population. we found the addition of
pooled NAAT after third-generation ELISA had a cost-
effectiveness ratio of $3360 per gained QALY, which is far
below the levels of the general population and MSM high-risk
populations abroad [25,36,37]. The input-output ratio was
1:16.9. Some studies have shown that utilizing pooled NAAT
after HIV antibody assay was not cost-effective in populations
with low HIV incidences [25,37]. However, this study demon-
strated that, for a high-risk population with an HIV incidence as
high as 7.1/100person years, this strategy could prevent a much
larger subsequent expense on treatment and monitoring in the
long run.
In conclusion, the addition of the pooled NAAT to the current
screening strategy of third generation ELISA HIV antibody test
and WB tests in high risk populations at voluntary counseling &
testing centers can help to improve early diagnosis of acute HIV
infections, especially within window period cases Further im-
provement may be seen if fourth generation ELISA is adopted.
This strategy will assist in controlling HIV transmission, allow
long-term savings in government funds allocated to treating and
preventing HIV/AIDS, and ultimately help to fight HIV/AIDS
more efficiently, effectively, and economically.
Screening Acute HIV Infections in MSM
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Ethics statement and study subjects
An open prospective cohort of MSM was recruited by the
categorical snowball sampling method in three cities of Liaoning
Province: Shenyang, Anshan and Fushun, between February 2009
and September 2010. All consenting persons who presented for
HIV counseling and testing at Voluntary Counseling and Testing
sites in these 3 cities, volunteered to participate in this study and
met the following criteria were included. The criteria included:
male, above 18 years of age, having at least one male sexual
partner in the past 12 months, and physically able. All cases in the
MSM high-risk cohort provided written informed consent for the
collection of samples and subsequent analyses, and completed a
questionnaire administered by trained interviewers. Interviews
were conducted and blood samples were obtained and tested for
HIV at follow-up visits every 10 weeks. All participants were given
general information about HIV and were informed how to
practice safe sexual behaviors during the course of the pre- and
post-test counseling provided by this study. All HIV positive
participants were informed to bring their male sex partners to the
testing site to be tested for HIV. This study was approved by the
Medical Research Ethics Committee of No. 1 Hospital of China
Medical University and written informed consent was obtained
from all participants.
HIV Antibody Screening
EDTA anticoagulant whole blood was collected in sterile
condition. Plasma was separated within 6 hours. All of the plasma
was tested with a third-generation HIV Antibody ELISA test,
Vironostika HIV-1/2 Microelisa System, (BioMe ´rieux, Holland)
within 24 hours according to the manufacturer’s instructions.
Negative samples were tested with pooled NAAT. Positive samples
were retested using the same ELISA test and an additional rapid
test, Determine HIV 1/2 (Abbot, USA). Once the samples were
determined to be both positive or to contain at least one positive
result, HIV status was confirmed with western blot assay within
24 hours. If the results were both negative, the plasma was
detected with pooled NAAT within one week (Figure 2).
Western Blot assays (WB)
The HIV-1/2 western blot assay HIV Blot 2.2 WB (Genelabs
Diagnostics, Singapore) was used for confirming HIV-1 infection.
Negative, weak positive and strong positive controls were included
each time according to the manufacturer’s instructions. The
participants were divided into 3 groups (chronic HIV infection,
acute HIV infection and recent HIV infection) according to the
national HIV detection guidelines. In brief, chronic HIV infection
was diagnosed if all HIV-1 specific bands were detected in the WB
and the possibility of recent HIV infection was excluded based
upon the high-risk behavior information in the epidemiology
Figure 2. The Algorithm of the Procedures of the MSM Voluntary Counseling & Testing centers for HIV Testing and Diagnosis. HIV
detection procedure, detecting time, algorithm of HIV-1 antibody screening and Pooled NAAT process, diagnostic criteria and principles of
management are shown in the flow chart.
doi:10.1371/journal.pone.0028792.g002
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bands were not up to the positive standard, yet demonstrated an
increasing trend in the follow-up blood samples. Recent HIV
infection was characterized if the plasma became HIV-1 positive
during the follow-up visits. Recent and acute HIV infections were
both included in the calculation of HIV incidence density. The
negative or indeterminate samples in WB were detected with
NAAT individually without mixing.
Pooled or Individual NAAT
According to the follow-up frequency and daily number of
clinical patients in our cohort, a 24-sample mini-pool (664)
strategy was adopted. Every 6 samples were mixed to 4 crosswise
second level pools, every 4 samples were mixed to 6 lengthways
second level pools, and the 4 crosswise second level pools were
mixed to a first level pool (Figure 3). A commercial HIV RNA
quantitative detection assay, COBAS AmpliPrep/COBAS Taq-
Man HIV-1 Test (Roche, Germany), was used in HIV-1 NAAT. If
the first level pool was positive, the 10 second level pools were
detected at the same time in the following day to validate the
positive sample. Negative control, weak positive control, strong
positive control, negative pool control, and positive pool control
were used in the pooled NAAT each time. Samples with positive
ELISA but negative or indeterminate WB results were subjected to
NAAT directly without mixing. All NAAT positive cases were
followed-up. If a follow-up sample became positive in WB, the case
was diagnosed as a window period acute HIV infection and
included in the calculation for HIV incidence. Participants without
seroconversion were followed-up continually according to the
previous schedule and participants with RNA copy number above
5000 copies/ml were followed-up until they were confirmed with
WB. Participants with RNA copy number between 50–5000
copies/ml were reexamined with newly collected blood. NAAT
negative samples were also followed according to the previous
follow-up schedule. The algorithms of the detection and follow-up
procedures are shown in Figure 2.
Gained quality-adjusted life years (QALYs) and Averted
Lifetime Medical Costs by Pooled NAAT Screening for AHI
We evaluated QALYs gained from transmissions averted and
the input-output ratio for pooled NAAT after third generation
ELISA test. To describe secondary HIV transmission (table 2), we
used the basic reproductive number, R0.R 0 can be interpreted as
the lifetime number of subsequent infections, attributable to a
single infected individual in a susceptible population. According to
a mathematical model using a sex-role-preference framework to
predict HIV infection in the MSM population [38], each HIV-
infected MSM may on average transmit HIV to 3.8 persons
during the window period without any behavioral intervention
and therapy. In this study we estimated a 25% transmission
possibility in the acute HIV infection stage based on methods
mentioned in a previous report [39]. The transmission rates for
people unaware of their HIV serostatus were reported to be 3.5
times higher than those who are aware of their HIV status [40].
The QALYs gained were expressed as the difference between
QALYs for a partner with and without HIV infection. We
designated an uninfected person with a QALY of 1.0. Partners
were estimated to become infected at the age of 33 based on the
average age of AHI in this cohort. According to the World Health
Report 2006, Chinese males have an average life span of 72 years.
The additional life expectancy for HIV-1 patients treated with
HAART (Highly Active Anti-Retroviral Therapy) was 32 years
[41], compared to 39 years for healthy people. The acute HIV
infection diagnosis can avert 7 QALYs lost in every HIV
transmission. Cost-utility estimations were calculated by subtract-
ing projected HIV treatment costs for HIV infections averted from
total AHI program costs and dividing by the QALYs gained for
each averted HIV infection.
Cost-utility ratio CUR ðÞ ~
C{AT
AQ
A~R0   Aacute   b
Acknowledgments
We thank Christiana Zhang of Georgetown University School of Medicine
for providing editorial help. We are also indebted to the subjects for their
participation.
Figure 3. 24 Mini Pool Mix and Split Process. Every 6 samples
were mixed to 4 crosswise second level pools, every 4 samples were
mixed to 6 lengthways second level pools, and the 4 crosswise second
level pools were mixed to a first level pool. If the first level pool was
positive, the 10 second level pools were detected at the same time.
doi:10.1371/journal.pone.0028792.g003
Table 2. Explanation of Abbreviation Symbol.
Abbreviation Symbol Explanatory Note
R0 the basic reproduction number for HIV
transmission among Chinese MSM.
Aacute transmission that might occur in acute/recent HIV
infection stage
b decreased HIV transmission risk after knowing HIV
infection status. (3.521)/3.5
T expense for treatment and monitoring life
expectancy of second generation transmitted HIV
infected patients
Q QALYs lost due to HIV infection for each patient
doi:10.1371/journal.pone.0028792.t002
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